Bank of Montreal’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-21
Closed -$3K 4698
2019
Q4
$3K Hold
21
﹤0.01% 4756
2019
Q3
$4K Hold
21
﹤0.01% 4587
2019
Q2
$5K Hold
21
﹤0.01% 4679
2019
Q1
$9K Hold
21
﹤0.01% 3917
2018
Q4
$7K Hold
21
﹤0.01% 3992
2018
Q3
$13K Hold
21
﹤0.01% 3850
2018
Q2
$16K Hold
21
﹤0.01% 3823
2018
Q1
$17K Hold
21
﹤0.01% 3609
2017
Q4
$16K Hold
21
﹤0.01% 3653
2017
Q3
$18K Hold
21
﹤0.01% 3557
2017
Q2
$19K Sell
21
-11
-34% -$9.35K ﹤0.01% 3554
2017
Q1
$29K Sell
32
-752
-96% -$705K ﹤0.01% 3257
2016
Q4
$787K Sell
784
-2,575
-77% -$2.66M ﹤0.01% 1976
2016
Q3
$6.66M Sell
3,359
-1,486
-31% -$2.78M 0.01% 979
2016
Q2
$8.24M Sell
4,845
-1,919
-28% -$3.24M 0.01% 892
2016
Q1
$11.8M Sell
6,764
-631
-9% -$1M 0.01% 673
2015
Q4
$13M Buy
+7,395
New +$13.1M 0.02% 633
2013
Q4
Sell
-3
Closed -$9K 3925
2013
Q3
$9K Buy
+3
New +$8.77K ﹤0.01% 3460

Other funds holding TRIB

Bank of Montreal's TRIB Position: Q1 2020 in Review

Bank of Montreal sold out of Trinity Biotech (TRIB) in Q1 2020, closing a stake of 21 shares — an estimated $3K sold.

Bank of Montreal first reported a position in TRIB in Q3 2013 and held it in 18 quarters. The position peaked at $13M in Q4 2015. 22 funds tracked by Wall St. Rank hold TRIB as of Q1 2020.

  • Bank of Montreal reported no remaining Trinity Biotech position as of Q1 2020 after selling out during the quarter.
  • Bank of Montreal sold 21 Trinity Biotech shares in Q1 2020, an estimated $3K.
  • Bank of Montreal first reported a position in Trinity Biotech in Q3 2013 and held it in 18 quarters.
  • Bank of Montreal's Trinity Biotech position peaked at $13M in Q4 2015.
  • 22 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2020.

Based on Bank of Montreal's 13F filing for Q1 2020, filed 13 May 2020.